Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of Syngene International. For a sector overview, read our pharmaceuticals sector report.

Live BSE Quotes Mar 19, 2018 10:37:00 AM
Price (Rs)541.85 Open (Rs) 554.75 High (Rs) 554.75 Low (Rs) 541.00
% Change-1.24 Volume 63,212 Value (Rs) 34,251,422 52-Week H/L 670.00 / 430.00
Live NSE Quotes Mar 19, 2018 10:39:59 AM
Price (Rs)538.45 Open (Rs) 553.40 High (Rs) 554.15 Low (Rs) 538.05
% Change-1.62 Volume 8,366 Value (Rs) 4,576,118 52-Week H/L 672.00 / 430.10
  BSE Sensex | CNX Nifty


SYNGENE INTERNATIONAL share price is down 1.2% to Rs 541.9 on the BSE. On the NSE, the SYNGENE INTERNATIONAL share price is down 1.6% to Rs 538.5. The total volume of shares traded is 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading down by 0.5%. And the benchmark S&P BSE SENSEX is at 33,098.2 (down 0.2%).

Over the last 30 days, the SYNGENE INTERNATIONAL share price is down 6.6%. And over the last one year, SYNGENE INTERNATIONAL share price is up 3.5%.

Today's Market

Sensex Opens on a Flat Note; Metal & Energy Stocks in Red(09:30 am)

Asian stock markets are trading on a mixed note after it was reported that the Federal Reserve is likely to deliver a hike in US interest rates.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Best Blue-Chip Stocks to Ride Sensex 100,000(The 5 Minute Wrapup)

Mar 8, 2018

Here are the four criteria by which you can easily identify safe blue-chip stocks to consider investing in this market correction if valuations fall to reasonable levels.

This Phone Call Changed How I Look at Markets...And Will Change You as Well(Smart Contrarian)

Mar 8, 2018

Nifty is down almost 10% from its all-time highs. It may be difficult for retail traders to make money in such markets but not for the institutional traders. Here's how they survive and thrive in such difficult times.

Trump's Trade Wars Aren't Going to Make America Great Again(Vivek Kaul's Diary)

Mar 12, 2018

The American president like other politicians is just looking at the first order effects of his decision to impose tariffs.

Mirae Asset Emerging Bluechip Fund: A Cautiously Managed Midcap Fund(Outside View)

Mar 6, 2018

PersonalFN takes deeper look at the performance of Mirae Asset Emerging Bluechip Fund.

One Private Bank Trounces All Public-Sector Banks(Chart Of The Day)

Mar 12, 2018

The market capitalisation of private sector lender HDFC Bank now exceeds the market capitalisation of all public-sector banks combined.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in SYNGENE INTERNATIONAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks